HTG Molecular Diagnostics Hires Vice President of Molecular Diagnostic Sales
TUCSON, Ariz. (June, 2012) – HTG Molecular Diagnostics, a privately-held, Tucson-based provider of molecular-technology solutions, hired Steve Hagan as vice president of molecular diagnostic sales. Hagan joins HTG Molecular Diagnostics from Ventana Medical Systems, a member of the Roche group, where he most recently served as the senior director of digital pathology and workflow commercialization. In this capacity, he was instrumental in the largest capital close in the organization’s history. He joined Ventana in 1996 and served in a variety of progressively more responsible roles including senior director of US marketing and senior director of global commercialization. Prior to joining Ventana, Hagan was a member of the Abbot Laboratories sales force. He served four years of active duty in the U.S. Army (Airborne, Ranger, and Infantry units) and earned a B.A. in English and History from Virginia Military Institute.
TJ Johnson, CEO of HTG Molecular Diagnostics states, “With more than 20 years of success in diagnostic testing sales, Steve will be instrumental in achieving decentralization of and improving physicians’ access to fast and accurate gene expression data via HTG Molecular Diagnostics’ automated platform solution. His understanding of the market, both technically and commercially, will propel this organization toward our ultimate mission to deliver faster, more cost effective diagnostic information resulting in better patient care. Additionally, Steve’s proven strategic sales leadership and strong industry relationships will facilitate the placement of HTG’s diagnostic technologies in clinical laboratories around the world.”